What is Cutera?
Headquartered in Brisbane, California, Cutera has established itself as a premier developer of laser and energy-based medical systems since its inception in 1998. The company serves a global network of dermatologists and aesthetic practitioners, providing a sophisticated suite of tools designed to bridge the gap between clinical science and patient-centric care. By focusing on the development of intuitive, high-performance hardware, Cutera enables medical professionals to deliver safe, effective, and reproducible outcomes. Its market position is defined by a long-standing dedication to innovation, ensuring that practitioners remain at the forefront of non-invasive aesthetic treatments through reliable, science-backed technology.
How much funding has Cutera raised?
Cutera has raised a total of $54.4M across 2 funding rounds:
Stock Offering
$49.4M
Debt
$5M
Stock Issuance/Offering (2004): $49.4M, investors not publicly disclosed
Debt (2020): $5M led by PPP
Key Investors in Cutera
PPP
Public-Private Partnership
Undisclosed Investor
A strategic participant in the company's historical stock issuance, contributing to the foundational capital structure necessary for long-term growth.
What's next for Cutera?
With the infusion of recent capital, Cutera is well-positioned to accelerate its strategic initiatives, particularly in the expansion of its product portfolio and the deepening of its global distribution channels. As the demand for advanced dermatological solutions continues to rise, the company is expected to leverage this financing to enhance its research and development capabilities, potentially exploring new frontiers in energy-based therapeutic applications. By maintaining a focus on operational excellence and clinical efficacy, Cutera aims to reinforce its competitive advantage, ensuring that its enterprise-level infrastructure can support the evolving needs of the aesthetic medicine industry while driving long-term value for its stakeholders.
See full Cutera company page
